    <SEC-DOCUMENT>0001213900-19-016813-index.html : 20190827
    <SEC-HEADER>0001213900-19-016813.hdr.sgml : 20190827
    <ACCEPTANCE-DATETIME>20190827170027
    ACCESSION NUMBER:		0001213900-19-016813
    CONFORMED SUBMISSION TYPE:	8-K
    PUBLIC DOCUMENT COUNT:		4
    CONFORMED PERIOD OF REPORT:	20190827
    ITEM INFORMATION:		Regulation FD Disclosure
    ITEM INFORMATION:		Financial Statements and Exhibits
    FILED AS OF DATE:		20190827
    DATE AS OF CHANGE:		20190827

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
    		CENTRAL INDEX KEY:			0001711754
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		IRS NUMBER:				475205835
    		STATE OF INCORPORATION:			NV
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		8-K
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38793
    		FILM NUMBER:		191058185

    	BUSINESS ADDRESS:
    		STREET 1:		1200 PROSPECT STREET
    		STREET 2:		SUITE 525
    		CITY:			LA JOLLA
    		STATE:			CA
    		ZIP:			92037
    		BUSINESS PHONE:		8589643720

    	MAIL ADDRESS:
    		STREET 1:		1200 PROSPECT STREET
    		STREET 2:		SUITE 525
    		CITY:			LA JOLLA
    		STATE:			CA
    		ZIP:			92037
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>8-K
    <SEQUENCE>1
    <FILENAME>f8k082719_inmunebio.htm
    <DESCRIPTION>FORM 8-K
    <TEXT>
    Document 1 - file: f8k082719_inmunebio.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.1
    <SEQUENCE>2
    <FILENAME>f8k082719ex99-1_inmunebio.htm
    <DESCRIPTION>INMUNE BIO INVESTOR FACT SHEET
    <TEXT>
    Document 2 - file: f8k082719ex99-1_inmunebio.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>3
    <FILENAME>ex99-1_001.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 3 - file: ex99-1_001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>4
    <FILENAME>ex99-1_002.jpg
    <DESCRIPTION>GRAPHIC
    <TEXT>
    Document 4 - file: ex99-1_002.jpg

    </DOCUMENT>
    </SEC-DOCUMENT>